GSK Patient Assistance Program & Savings Offers
We have a range of programs and offers to help eligible patients get access and financial support for the GSK medicines they need.
Select one of the following options to find more information on:
- How to save on Prescription Medicines
- How to receive Coupons
Currently available for: TRELEGY Ellipta - Eligibility for Co-Pay Assistance
Currently available for: BENLYSTA, JEMPERLI, NUCALA, OJJAARA, and ZEJULA - Access to Vaccine Payment Assistance
Currently available for: BOOSTRIX, ENGERIX-B and SHINGRIX
Please note that all of our Patient Assistance programs are managed by the GSK Patient Access Programs Foundation. Availability varies for each patient and GSK product.
The GSK Patient Assistance Program for Prescription Medicines provides certain GSK medications at no cost to eligible patients.
FAQs About the Patient Assistance Program for Prescription Medicines
Eligibility criteria apply. This program does not constitute health insurance. GSK's coupons are subject to change or discontinuation without notice.
FAQs About GSK Savings Offers
The GSK Co-pay Assistance Program can help eligible patients with their out-of-pocket costs for certain GSK prescription medicines. At this time, Co-pay programs are available for:
Eligibility criteria apply. These programs do not constitute health insurance. GSK's Co-pay programs are subject to change or discontinuation without notice.
Patients who need assistance meeting the cost of GSK vaccines may find the help they need through this program. Patients must enroll in the program through their healthcare provider. The following vaccines are currently included in the program.
- BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)
- ENGERIX-B [Hepatitis B Vaccine (Recombinant)]
- SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
Eligibility criteria apply. This program does not constitute health insurance. Vaccines included in the program are subject to change or discontinuation without notice.
FAQs About the Patient Assistance Program for Vaccines